|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.95 TWD | -0.36% |
|
+0.72% | -3.12% |
Excelsior Biopharma Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 187.98 million compared to TWD 173.65 million a year ago. Net loss was TWD 23.91 million compared to TWD 10.13 million a year ago.
Basic loss per share from continuing operations was TWD 0.52 compared to TWD 0.22 a year ago. Diluted loss per share from continuing operations was TWD 0.52 compared to TWD 0.22 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.12% | 40.26M | |
| +34.00% | 704B | |
| +26.84% | 577B | |
| -7.75% | 348B | |
| +18.53% | 327B | |
| +4.95% | 288B | |
| +14.98% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -4.89% | 147B |
EXCELSIOR BIOPHARMA INC. 
